Conversion to mycophenolate mofetil (MMF) in pediatric kidney transplant recipients.

被引：0
|
作者：
Machado, PGP [1 ]
Nogueira, PCK [1 ]
Park, SI [1 ]
Tedesco-Silva, H [1 ]
Pestana, JOM [1 ]
机构：
[1] UNIFESP, Hosp Rim & Hipertensao, Div Nephrol, Sao Paulo, Brazil
来源：
PEDIATRIC TRANSPLANTATION | 2005年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
195
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [41] Clinical Significance of Mycophenolate Mofetil Withdrawal in Kidney Transplant Recipients
    Park, Woo Yeong
    Paek, Jin Hyuk
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    [J]. TRANSPLANTATION PROCEEDINGS, 2019, 51 (08) : 2633 - 2636
  • [42] Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients
    Wojciechowski, D.
    Chandran, S.
    Webber, A.
    Hirose, R.
    Vincenti, F.
    [J]. TRANSPLANTATION PROCEEDINGS, 2017, 49 (08) : 1773 - 1778
  • [43] Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients
    Miller, J
    Mendez, R
    Pirsch, JD
    Jensik, SC
    [J]. TRANSPLANTATION, 2000, 69 (05) : 875 - 880
  • [44] MYCOPHENOLATE MOFETIL AND THE INCIDENCE OF SKIN CANCER IN KIDNEY TRANSPLANT RECIPIENTS
    Yusuf, Sarah
    Bheemreddy, Himaja
    Ahmed, Imtiaz
    Krishnan, Nithya
    [J]. TRANSPLANTATION, 2020, 104 (09) : S603 - S603
  • [45] UGT POLYMORPHISMS MAY CONTRIBUTE TO SIDE EFFECTS OF MYCOPHENOLATE MOFETIL IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Fukuda, T.
    Prausa, S. E.
    Maseck, D.
    Zhang, K.
    Nick, T. G.
    Liu, C.
    Goebel, J.
    Vinks, A. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S67 - S67
  • [46] Prevalence of Mycophenolate Mofetil discontinuation and subsequent outcomes in pediatric kidney transplant recipients: A PNRC study
    Moudgil, Asha
    Sgambat, Kristen
    Benoit, Elizabeth
    Seifert, Michael
    Bharadwaj, Madhumithaa
    Jain, Amrish
    Mansuri, Asif
    Harshman, Lyndsay
    Katsoufis, Chryso
    Somers, Michael
    [J]. PEDIATRIC TRANSPLANTATION, 2022, 26
  • [47] Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporin.
    Lobritto, SJ
    Rosenthal, P
    Bouw, R
    Leung, M
    Snell, P
    Mamelok, R
    [J]. PEDIATRIC TRANSPLANTATION, 2005, 9 : 114 - 115
  • [48] Prevalence of mycophenolate mofetil discontinuation and subsequent outcomes in pediatric kidney transplant recipients: A PNRC study
    Moudgil, Asha
    Sgambat, Kristen
    Benoit, Elizabeth
    Seifert, Michael E.
    Bharadwaj, Madhumithaa
    Jain, Amrish
    Mansuri, Asif
    Harshman, Lyndsay
    Katsoufis, Chryso
    Somers, Michael
    [J]. PEDIATRIC TRANSPLANTATION, 2024, 28 (01)
  • [49] The effect of selective bowel decontamination on the pharmacokinetics of mycophenolate mofetil in liver transplant recipients.
    Schmidt, LE
    Rasmussen, A
    Norrelykke, MR
    Poulsen, HE
    Hansen, BA
    [J]. HEPATOLOGY, 2001, 34 (04) : 645A - 645A
  • [50] Mycophenolate Mofetil Monotherapy Favour Impact the Histological Course in HCV Transplant Recipients.
    Manzia, Tommaso Maria
    Toti, Luca
    Lenci, Ilaria
    Angelico, Roberta
    Monaco, Andrea
    Manuelli, Matteo
    De Luca, Linda
    Tariciotti, Laura
    Baiocchi, Leonardo
    Tisone, Giuseppe
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 329 - 329
12345